The Patent Finder

Ultra-Microrigin Biomedical Technology Co., Ltd.

Also on record
Records under this name other than patents Ultra-Microrigin Biomedical Technology Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Ultra-Microrigin Biomedical Technology Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,517,998Device Method of Making, Separating, and Purifying Artepillin C in Propolis
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,214,719Method of culturing Antrodia cinnamomea with high triterpenoids
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 11,739,044Method for synthesizing artepillin C and intermediate compound thereof
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,751,956Method of using supercritical fluid technology to separate and purify functional components of Antrodia camphorata
Formerly held
Lapsed on the fee record
Ended Sep 5, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 5, 2025USPTO record
US 9,567,365Method for separating estrogen from placenta
Formerly held
Lapsed on the fee record
Ended Feb 14, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 14, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited